Well-timed stock bets have generated big profits for senior executives and board members at companies developing vaccines and treatments. On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S.
from Pocket https://www.nytimes.com/2020/07/25/business/coronavirus-vaccine-profits-vaxart.html
via TV Aerials Leeds
No comments:
Post a Comment